extem a10 (Rotem Industries)
Structured Review
Extem A10, supplied by Rotem Industries, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/extem/a10+assay+clauss+fibrinogen+fibtem+%E2%80%A2/pm41125237-2649-7-18
Average 86 stars, based on 1 article reviews
Images
Related Articles
Functional Assay:Article Title: Efficacy and safety of human fibrinogen concentrate (BT524) in patients with major haemorrhage undergoing major orthopaedic or abdominal surgery (AdFIrst): a randomised, active-controlled, multicentre, partially blinded, phase 3 non-inferiority trial Article Snippet: .. Spinal surgery: FC dose was calculated based on body weight (BW) and functional fibrinogen level from clot amplitude after 10 min ( FIBTEM Assay:Article Title: Efficacy and safety of human fibrinogen concentrate (BT524) in patients with major haemorrhage undergoing major orthopaedic or abdominal surgery (AdFIrst): a randomised, active-controlled, multicentre, partially blinded, phase 3 non-inferiority trial Article Snippet: .. Spinal surgery: FC dose was calculated based on body weight (BW) and functional fibrinogen level from clot amplitude after 10 min ( Article Title: Efficacy and safety of human fibrinogen concentrate (BT524) in patients with major haemorrhage undergoing major orthopaedic or abdominal surgery (AdFIrst): a randomised, active-controlled, multicentre, partially blinded, phase 3 non-inferiority trial Article Snippet: .. • Markers of coagulation (Coagulation activation tests) • Plasma activity of Article Title: ISBT and ANZSBT abstracts of the joint Blood2025-ISBT 36th Regional Congress, Perth, Australia, 26-29 October 2025. Article Snippet: Medicinal products derived from human blood and plasma donations are essential to healthcare worldwide.. In 2010, the World Health Assembly adopted resolution WHA 63.12, urging Member States to establish, implement, and support nationally coordinated, well-managed, and sustainable blood and plasma programs to achieve self-sufficiency.. To monitor the global availability, safety, and accessibility of blood for transfusion, the World Health Organization (WHO) launched the Global Database on Blood Safety (GDBS) in 1998. Article Title: Viscoelastic haemostatic assays in chronic liver disease—Profiling coagulation in the emergency department Article Snippet: .. ROTEM: Article Title: Viscoelastic haemostatic assays in chronic liver disease—Profiling coagulation in the emergency department Article Snippet: .. ROTEM: Article Title: Efficacy and safety of human fibrinogen concentrate (BT524) in patients with major haemorrhage undergoing major orthopaedic or abdominal surgery (AdFIrst): a randomised, active-controlled, multicentre, partially blinded, phase 3 non-inferiority trial Article Snippet: .. • Markers of coagulation (Coagulation activation tests) • Plasma activity of Coagulation:Article Title: Efficacy and safety of human fibrinogen concentrate (BT524) in patients with major haemorrhage undergoing major orthopaedic or abdominal surgery (AdFIrst): a randomised, active-controlled, multicentre, partially blinded, phase 3 non-inferiority trial Article Snippet: .. • Markers of coagulation (Coagulation activation tests) • Plasma activity of Article Title: Efficacy and safety of human fibrinogen concentrate (BT524) in patients with major haemorrhage undergoing major orthopaedic or abdominal surgery (AdFIrst): a randomised, active-controlled, multicentre, partially blinded, phase 3 non-inferiority trial Article Snippet: .. • Markers of coagulation (Coagulation activation tests) • Plasma activity of Activation Assay:Article Title: Efficacy and safety of human fibrinogen concentrate (BT524) in patients with major haemorrhage undergoing major orthopaedic or abdominal surgery (AdFIrst): a randomised, active-controlled, multicentre, partially blinded, phase 3 non-inferiority trial Article Snippet: .. • Markers of coagulation (Coagulation activation tests) • Plasma activity of Article Title: Efficacy and safety of human fibrinogen concentrate (BT524) in patients with major haemorrhage undergoing major orthopaedic or abdominal surgery (AdFIrst): a randomised, active-controlled, multicentre, partially blinded, phase 3 non-inferiority trial Article Snippet: .. • Markers of coagulation (Coagulation activation tests) • Plasma activity of Clinical Proteomics:Article Title: Efficacy and safety of human fibrinogen concentrate (BT524) in patients with major haemorrhage undergoing major orthopaedic or abdominal surgery (AdFIrst): a randomised, active-controlled, multicentre, partially blinded, phase 3 non-inferiority trial Article Snippet: .. • Markers of coagulation (Coagulation activation tests) • Plasma activity of Article Title: Efficacy and safety of human fibrinogen concentrate (BT524) in patients with major haemorrhage undergoing major orthopaedic or abdominal surgery (AdFIrst): a randomised, active-controlled, multicentre, partially blinded, phase 3 non-inferiority trial Article Snippet: .. • Markers of coagulation (Coagulation activation tests) • Plasma activity of Activity Assay:Article Title: Efficacy and safety of human fibrinogen concentrate (BT524) in patients with major haemorrhage undergoing major orthopaedic or abdominal surgery (AdFIrst): a randomised, active-controlled, multicentre, partially blinded, phase 3 non-inferiority trial Article Snippet: .. • Markers of coagulation (Coagulation activation tests) • Plasma activity of Article Title: Efficacy and safety of human fibrinogen concentrate (BT524) in patients with major haemorrhage undergoing major orthopaedic or abdominal surgery (AdFIrst): a randomised, active-controlled, multicentre, partially blinded, phase 3 non-inferiority trial Article Snippet: .. • Markers of coagulation (Coagulation activation tests) • Plasma activity of |

